New drug aims to stop deadly clots without causing bleeding
NCT ID NCT05785819
Summary
This study tested a new drug, VLX-1005, for people suspected of having heparin-induced thrombocytopenia (HIT), a serious reaction to the common blood thinner heparin that causes low platelets and dangerous clots. Participants received the current standard treatment and were randomly assigned to also get either VLX-1005 or a placebo. The main goal was to see if VLX-1005 could help platelets recover faster and reduce the risk of life-threatening clots and bleeding complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA, IMMUNE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carilion Medical Center
Roanoke, Virginia, 24014, United States
-
Duke University
Durham, North Carolina, 27710, United States
-
Georgetown University
Washington D.C., District of Columbia, 20007, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Stanford University
Stanford, California, 94305, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Washington
Seattle, Washington, 98195, United States
-
Universiy of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Versiti at Froedtert Hospital
Milwaukee, Wisconsin, 53226, United States
-
Yale University
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.